about
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision d...
Read More
29.69
-0.29
(-0.97%)
2.0M
XNAS Volume
XNAS 27 Feb, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Alumis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..